CIK: 0001602263
Total reported value
$379.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Avexis INC | Stock-Other | 27.47% | — | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 11.11% | -4.69% | +3.26% | |
| 3 | ASND | Ascendis Pharma A/S | Stock-Other | 10.69% | -8.61% | EXIT | |
| 4 | ARGX | Argenx Se - Adr | Stock-Healthcare | 9.83% | — | +0.41% | |
| 5 | ZGNXEUR | Zogenix INC | Stock-Other | 8.20% | — | -5.84% | |
| 6 | ANAB | Anaptysbio INC | Stock-Other | 6.82% | — | +68.64% | |
| 7 | ✓ | DBV Technologies | Stock-Other | 4.96% | — | +80.30% | |
| 8 | ✓ | Obseva SA | Stock-Other | 4.65% | -5.57% | +41.92% | |
| 9 | SVRA | Savara INC | Stock-Other | 4.48% | — | — | |
| 10 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 2.92% | -3.14% | EXIT | |
| 11 | BLPHEUR | Bellerophon Therapeutics INC | Stock-Other | 2.32% | -0.70% | — | |
| 12 | EWTX | Edgewise Therapeutics, Inc. | Stock-Other | 2.19% | — | -23.78% | |
| 13 | SPRO | Spero Therapeutics INC | Stock-Other | 1.37% | -0.72% | — | |
| 14 | RARXEUR | Ra Pharmaceuticals INC | Stock-Other | 1.11% | -6.10% | EXIT | |
| 15 | ✓ | Catalyst Biosciences INC | Stock-Other | 0.77% | — | — | |
| 16 | ✓ | Stock-Other | 0.44% | — | — | ||
| 17 | ✓ | ARCA biopharma Inc | Stock-Other | 0.35% | — | — | |
| 18 | ✓ | Lipocine INC New | Stock-Other | 0.32% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ARGX | Argenx Se - Adr | +5.8% | +0.41% | Add |
| 2 | ANAB | Anaptysbio INC | +5.2% | +68.64% | Add |
| 3 | ✓ | Obseva SA | +1.5% | +41.92% | Add |
| 4 | BLPHEUR | Bellerophon Therapeutics INC | +1% | — | Unchanged |
| 5 | ✓ | ARCA biopharma Inc | 0% | — | Unchanged |
| 6 | ✓ | Lipocine INC New | -0.1% | — | Unchanged |
| 7 | ✓ | Avexis INC | -0.2% | — | Unchanged |
| 8 | ✓ | -0.3% | — | Unchanged | |
| 9 | ZGNXEUR | Zogenix INC | -0.6% | -5.84% | Trim |
| 10 | ✓ | DBV Technologies | -1.2% | +80.30% | Add |
| 11 | EWTX | Edgewise Therapeutics, Inc. | -1.6% | -23.78% | Trim |
| 12 | BCRX | Biocryst Pharmaceuticals INC | -1.7% | -21.59% | Trim |
| 13 | RARXEUR | Ra Pharmaceuticals INC | -2% | -29.25% | Trim |
| 14 | ASND | Ascendis Pharma A/S | -2.3% | -14.32% | Trim |
| 15 | BHVN | Biohaven Ltd. | -5.7% | +3.26% | Add |
| 16 | SVRA | Savara INC | — | NEW | New buy |
| 17 | MYOKEUR | Myokardia INC | — | EXIT | Sold out |
| 18 | SPRO | Spero Therapeutics INC | — | NEW | New buy |
| 19 | ✓ | Catalyst Biosciences INC | — | NEW | New buy |
| 20 | 4XC1 | Kalvista Pharmaceuticals INC | — | EXIT | Sold out |
| 21 | MDGL | Madrigal Pharmaceuticals INC | — | EXIT | Sold out |
| 22 | ADVMCHF | Adverum Biotechnologies INC | — | EXIT | Sold out |
| 23 | ✓ | Ocera Therapeutics INC | — | EXIT | Sold out |
| 24 | ✓ | Axovant Sciences LTD | — | EXIT | Sold out |